Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine for Worsening Parkinsonism
NCT00472355Phase 2Withdrawn
- Sponsor
- Oregon Health & Science University
- Start
- Oct 2005
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apomorphine in Parkinson's disease (PD), sponsored by Oregon Health & Science University. Planned start Oct 2005; status: withdrawn.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00472355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472355.